A, G., R, S., W, B., B, V., HS, S., PA, H., . . . WC, G. (2021). Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In Vivo. Journal of virology, 95(8), . https://doi.org/10.1128/JVI.02393-20
Chicago Style (17th ed.) CitationA, Gramatica, et al. "Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In Vivo." Journal of Virology 95, no. 8 (2021). https://doi.org/10.1128/JVI.02393-20.
MLA (9th ed.) CitationA, Gramatica, et al. "Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity Ex Vivo and In Vivo." Journal of Virology, vol. 95, no. 8, 2021, https://doi.org/10.1128/JVI.02393-20.
Warning: These citations may not always be 100% accurate.